Medtronic posts strong Q1 results and raises FY27 revenue and EPS guidance
Medtronic reported strong Q1 revenue and EPS growth, driven by broad performance across major business units and robust demand. It raised FY27 guidance for both revenue and EPS, citing continued innovation investment and strategic acquisitions.
Q1 FY27 delivered strong revenue and EPS growth, driven by broad-based performance across major business units and robust demand.
Guidance for FY27 was raised for both revenue and EPS, with continued investment in innovation and strategic acquisitions supporting long-term growth.Based on Medtronic…